- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07681934
Swaddling and Breast Milk Odor for Stress and Comfort in Late Preterm Babies Receiving High-Flow Breathing Support Through the Nose
The Effect of the Safe Swaddling Method and the Scent of Breast Milk on Physiological Parameters, Stress, and Comfort Levels in Premature Newborns Receiving Mechanical Ventilator Support: A Randomized Controlled Study
This study compared two approaches to reducing stress and improving comfort in babies born between 34 and 36 completed weeks of pregnancy who were receiving high-flow breathing support through small tubes in the nose.
Seventy-two babies were assigned by chance to one of three groups, with 24 babies in each group. One group was gently swaddled for 20 minutes. A second group was exposed for 20 minutes to the smell of freshly expressed milk from each baby's own mother. The third group received the neonatal intensive care unit's usual care and was observed for 20 minutes.
The study team assessed stress and comfort and recorded heart rate, breathing rate, blood oxygen level, and body temperature at the start of the observation period and again at 5 and 20 minutes. The purpose was to compare how these measures changed over time across the three groups.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Karatay
-
Konya, Karatay, Turquia (Türkiye), 42040
- KTO Karatay University
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Gestational age at birth of 34 weeks 0 days to 36 weeks 6 days, inclusive.
- Within the first 28 days of life at enrollment.
- Receiving noninvasive respiratory support via a high-flow nasal cannula (HFNC).
- Birth weight of at least 1,500 g.
- The infant's mother was able to provide expressed breast milk.
- No clinical condition that precluded safe positioning or swaddling.
- Written informed consent obtained from a parent.
Exclusion Criteria:
- A painful procedure within 1 hour before the start of the planned study session.
- Receipt of a medication with analgesic or sedative effects within 6 hours before the start of the planned study session.
- Previous surgery.
- An active or treatment-requiring clinical condition that could affect physiological measurements or the stress response, such as hypoglycemia, hyperbilirubinemia, or acute infection.
- Cerebral hypoxia or ischemia.
- Intraventricular hemorrhage.
- A major congenital anomaly.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Maternal Breast Milk Odor
Infants were exposed for 20 minutes to the odor of freshly expressed breast milk from their own mothers. Ten drops of milk were applied to sterile gauze placed in a sterile container. The container was positioned inside the incubator approximately 1-2 cm from the infant's nose and remained in place throughout the exposure period. |
Ten drops of freshly expressed breast milk from each infant's own mother were applied to sterile gauze in a sterile container. The container was placed inside the incubator near the infant's nose for 20 minutes. |
|
Experimental: Safe Swaddling
Infants were positioned supine and swaddled for 20 minutes using a thin, breathable muslin cloth measuring 90 × 90 cm. The upper limbs were held alongside the trunk in slight flexion. The lower limbs were left free to allow hip flexion and abduction. The cloth was secured loosely enough to permit chest expansion and spontaneous movement. |
Infants were swaddled in the supine position for 20 minutes using a thin, breathable muslin cloth measuring 90 × 90 cm. The cloth was secured loosely to allow chest expansion and spontaneous movement, and the lower limbs were left free to permit hip flexion and abduction. |
|
Sem intervenção: Standard Care
Infants received the neonatal intensive care unit's standard care during a 20-minute observation period. No additional study intervention was administered. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Newborn Stress Scale Total Score Over Time
Prazo: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
Stress was assessed using the Newborn Stress Scale. The scale comprises eight observational domains, each scored from 0 to 2. Total scores range from 0 to 16, with higher scores indicating greater stress. Changes in total scores across the three assessment time points were compared among the study groups. |
At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Premature Infant Comfort Scale Total Score
Prazo: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
Comfort was assessed using the Turkish version of the Premature Infant Comfort Scale. Seven indicators are each scored from 1 to 5. Total scores range from 7 to 35, with lower scores indicating greater comfort. |
At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
|
Heart Rate
Prazo: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
Heart rate was read directly from the bedside monitor and recorded in beats per minute. |
At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
|
Respiratory Rate
Prazo: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
Respiratory rate was read directly from the bedside monitor and recorded in breaths per minute. |
At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
|
Peripheral Oxygen Saturation (SpO₂)
Prazo: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
Peripheral oxygen saturation was read directly from the bedside monitor and recorded as a percentage. |
At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
|
Body Temperature
Prazo: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
Body temperature was read directly from the bedside monitor and recorded in degrees Celsius (°C). |
At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Hediye Karakoç, KTO Karatay Üniversitesi
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- KARATAYU-SBF-ES-01
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Security
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .